Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Oxidative stress: a link between cardiovascular disease and psychiatric illness?

McCarthy MJ.

Acta Psychiatr Scand. 2014 Sep;130(3):161-2. doi: 10.1111/acps.12269. Epub 2014 Mar 24. No abstract available.

PMID:
24660876
2.

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.

Assies J, Mocking RJ, Lok A, Ruhé HG, Pouwer F, Schene AH.

Acta Psychiatr Scand. 2014 Sep;130(3):163-80. doi: 10.1111/acps.12265. Epub 2014 Mar 21. Review.

3.

Fatty acids and oxidative stress in psychiatric disorders.

Tsaluchidu S, Cocchi M, Tonello L, Puri BK.

BMC Psychiatry. 2008 Apr 17;8 Suppl 1:S5. doi: 10.1186/1471-244X-8-S1-S5.

4.

Homocysteine levels, paraoxonase 1 (PON1) activity, and cardiovascular risk.

Vos E.

JAMA. 2008 Jul 9;300(2):168-9; author reply 169. doi: 10.1001/jama.300.2.168. No abstract available.

PMID:
18612112
5.

Clinical diagnostics for homocysteine: a rogue amino acid?

Newton LA, Sandhu K, Livingstone C, Leslie R, Davis J.

Expert Rev Mol Diagn. 2010 May;10(4):489-500. doi: 10.1586/erm.10.19. Review.

PMID:
20465503
6.

N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical data.

Zeman M, Jirak R, Vecka M, Raboch J, Zak A.

Neuro Endocrinol Lett. 2012;33(8):736-48. Review.

PMID:
23391975
7.

Estrogen and homocysteine.

Dimitrova KR, DeGroot K, Myers AK, Kim YD.

Cardiovasc Res. 2002 Feb 15;53(3):577-88. Review.

8.

Homocysteine and oxidative stress.

Perna AF, Ingrosso D, De Santo NG.

Amino Acids. 2003 Dec;25(3-4):409-17. Epub 2003 Jul 31. Review.

PMID:
14661100
9.

Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders.

Mattson MP, Haberman F.

Curr Med Chem. 2003 Oct;10(19):1923-9. Review.

PMID:
12871094
10.

Cipla Medpro addresses the link between homocysteine and cardiovascular risk.

[No authors listed]

Cardiovasc J S Afr. 2003 Sep-Oct;14(5):280. No abstract available.

11.
12.

Homocysteine metabolism and various consequences of folate deficiency.

Tchantchou F.

J Alzheimers Dis. 2006 Aug;9(4):421-7. Review.

PMID:
16917151
13.

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

Mattson MP, Shea TB.

Trends Neurosci. 2003 Mar;26(3):137-46. Review.

PMID:
12591216
14.

Hyperhomocysteinemia, pteridines and oxidative stress.

Widner B, Enzinger C, Laich A, Wirleitner B, Fuchs D.

Curr Drug Metab. 2002 Apr;3(2):225-32. Review.

PMID:
12003353
15.

Folic acid and homocysteine in age-related disease.

Mattson MP, Kruman II, Duan W.

Ageing Res Rev. 2002 Feb;1(1):95-111. Review.

PMID:
12039451
16.

Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.

Blom HJ, Smulders Y.

J Inherit Metab Dis. 2011 Feb;34(1):75-81. doi: 10.1007/s10545-010-9177-4. Epub 2010 Sep 4. Review.

17.

Oxidative stress markers and cardiovascular disease: advantage of using these factors in combination with lifestyle factors for cardiovascular risk assessment.

Kawada T.

Int J Cardiol. 2012 May 17;157(1):119-20. doi: 10.1016/j.ijcard.2012.03.107. Epub 2012 Mar 30. No abstract available.

PMID:
22465344
18.

Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.

Basu S.

Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):219-25. doi: 10.1016/j.plefa.2010.02.031. Epub 2010 Apr 2. Review.

PMID:
20363116
19.

Adenosine-the missing link to understanding homocysteine pathogenicity or more smoke on the horizon?

Deussen A.

Cardiovasc Res. 2003 Aug 1;59(2):259-61. No abstract available.

20.

New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.

De Caterina R, Zampolli A, Madonna R, Fioretti P, Vanuzzo D.

Ital Heart J. 2004 Jun;5 Suppl 6:19S-24S. Review.

PMID:
15185912
Items per page

Supplemental Content

Write to the Help Desk